Heranba Industries Limited (HERANBA) AI Stock Analysis

• Market Cap: ₹11.82B
• Dividend Yield: 0.35%
• Average Volume (3M): 3.99K
• Price to Earnings (P/E): 385.2
• Beta (1Y): 1.44
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: IN
• Employees: 1,250
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Agricultural Inputs
• EPS (TTM): 1.52
• Shares Outstanding: 40,013,466
• 10 Day Avg. Volume: 4,133
• 30 Day Avg. Volume: 3,992
• PEG Ratio: -3.18
• Price to Book (P/B): 1.06
• Price to Sales (P/S): 0.63
• P/FCF Ratio: -5.09
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 48 Neutral
• Price Target: ₹302.00 ▲(6.71% Upside)

Heranba Industries Limited's stock score is primarily impacted by its mixed financial performance and technical indicators suggesting bearish momentum. The high P/E ratio indicates potential overvaluation, further weighing down the score. The lack of earnings call data and corporate events means these factors do not influence the overall score.

Heranba Industries Limited Business Overview & Revenue Model

Company Description

Heranba Industries Limited manufactures, markets, and sells a range of agrochemicals in India. The company provides intermediates, such as cypermethric acid chloride, high CIS CMA and CMAC, high trans CMA and CMAC, bromobenzenes, metaphenoxy benzaldehyde and benzyl alcohol, and NPBR; and technical products, including cypermethrin, deltamethrin, alpha cypermethrin, acephate, lambda cyhalothrin, bifenthrin, and tranfluthrin, as well as tricyclazole, hexaconazole, tebuconazole, glyphosate, metribuzin, clodinafop, and bispyribac sodium. It also offers formulations comprising emulsifiable concentrate, water dispersible granule, suspension concentrate, capsule suspension, oil dispersion, concentrated aqueous emulsions, suspoemulsion, and zc formulation. In addition, the company provides various pesticides, including insecticides, herbicides, fungicides, and public health products for pest control. Heranba Industries Limited also exports its products to approximately 65 countries. The company was formerly known as Heranba Industrial Chemicals Limited and changed its name to Heranba Industries Limited in July 1996. Heranba Industries Limited was incorporated in 1992 and is based in Mumbai, India.

How the Company Makes Money

Heranba Industries generates revenue primarily through the sale of its agrochemical products, which include a variety of pesticides, herbicides, and fungicides. The company has established multiple revenue streams by offering a comprehensive portfolio of formulations tailored to different crops and pest management needs. Additionally, HERANBA engages in exports, which contribute significantly to its income, tapping into international markets. The company benefits from strategic partnerships with agricultural cooperatives and distributors, thereby enhancing its market reach and sales volume. Furthermore, HERANBA invests in research and development to innovate new products that meet evolving agricultural challenges, which can lead to increased market share and profitability.

Heranba Industries Limited Financial Statement Overview

Summary

Heranba Industries Limited shows a mixed financial performance. While there is stability in some balance sheet metrics, income statement and cash flow challenges suggest operational inefficiencies and cash generation issues. The company should focus on improving profitability margins and cash flow management to ensure sustainable financial health.

Income Statement

Heranba Industries Limited demonstrated a volatile revenue and profit trajectory. The revenue growth rate has been inconsistent, with a notable decline in 2025 compared to 2024. Gross profit margins have been relatively stable, but the net profit margin significantly declined from 2024 to 2025, indicating increased operational challenges. The EBIT margin also decreased, reflecting potential inefficiencies. However, the EBITDA margin remained positive, suggesting some resilience in operational cash generation.

Balance Sheet

The company maintains a healthy equity position with an increasing total assets base. The debt-to-equity ratio is moderate, indicating balanced leverage, though debt levels have increased over the years. Return on equity has dropped significantly, indicating reduced profitability. The equity ratio remains strong, suggesting stability and lower financial risk.

Cash Flow

Free cash flow has been negative in recent years, highlighting challenges in cash generation after capital expenditures. The operating cash flow to net income ratio suggests operational cash generation issues, as seen in the declining operating cash flows. The free cash flow to net income ratio is also unfavorable, indicating that net income is not translating into free cash flow effectively.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	15.69B	14.17B	12.49B	13.11B	14.35B	12.02B
Gross Profit	4.88B	4.72B	3.70B	4.29B	5.04B	4.23B
EBITDA	1.07B	1.05B	893.40M	1.68B	2.79B	2.28B
Net Income	-77.90M	30.70M	348.90M	1.04B	1.89B	1.54B
Balance Sheet
Total Assets	0.00	18.13B	14.80B	11.62B	10.69B	8.43B
Cash, Cash Equivalents and Short-Term Investments	545.60M	426.00M	287.00M	1.22B	1.05B	847.80M
Total Debt	0.00	3.49B	1.65B	930.00M	539.62M	523.06M
Total Liabilities	-8.50B	9.63B	6.27B	3.52B	3.54B	3.15B
Stockholders Equity	8.50B	8.41B	8.43B	8.10B	7.14B	5.28B
Cash Flow
Free Cash Flow	0.00	-1.75B	-1.46B	611.90M	176.37M	362.99M
Operating Cash Flow	0.00	1.01B	1.07B	1.23B	981.75M	603.99M
Investing Cash Flow	0.00	-2.39B	-2.41B	-1.00B	-816.79M	-407.13M
Financing Cash Flow	0.00	1.52B	620.20M	-180.80M	-62.80M	619.00M

Heranba Industries Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 283.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:HERANBA, the sentiment is Negative. The current price of 283 is below the 20-day moving average (MA) of 302.71, below the 50-day MA of 315.03, and below the 200-day MA of 302.58, indicating a bearish trend. The MACD of -6.11 indicates Positive momentum. The RSI at 30.22 is Neutral, neither overbought nor oversold. The STOCH value of 2.89 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:HERANBA.

Heranba Industries Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SHARDACROP	65 Neutral	₹73.13B	16.19	―	1.16%	33.23%	107.47%
INSECTICID	64 Neutral	₹20.04B	13.38	―	0.73%	2.61%	24.65%
DHANUKA	64 Neutral	₹59.97B	21.18	―	0.15%	4.92%	4.47%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
SUMICHEM	59 Neutral	₹237.17B	43.71	―	0.25%	8.69%	12.26%
RALLIS	56 Neutral	₹50.89B	28.92	―	1.01%	0.91%	18.12%
HERANBA	48 Neutral	₹11.82B	385.17	―	0.35%	―	―

Heranba Industries Limited Corporate Events

Heranba Industries Conducts 33rd AGM Virtually, Reports Clean Audit

Heranba Industries Limited held its 33rd Annual General Meeting on September 24, 2025, via video conferencing, with key directors and officers in attendance. The meeting was chaired by Mr. Sadashiv Kanyana Shetty, and a total of 67 shareholders participated. The Chairman confirmed that the statutory and secretarial audit reports were free of qualifications or adverse remarks, indicating a stable financial and compliance position for the company.